Evidence map›Paper›PMID 41639728›Full record

ArticleTrials2026

Correction: Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.

Franz Schaefer, Giovanni Montini, Hee Gyung Kang, Johan Vande Walle, Joshua Zaritsky, Michiel F Schreuder, Mieczyslaw Litwin, Andrea Scalise, Helen Scott, James Potts and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Franz SchaeferPediatric Nephrology Division, Heidelberg University Hospital, Heidelberg, Germany. Franz.Schaefer@med.uni-heidelberg.de.
Giovanni MontiniDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Hee Gyung KangDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Johan Vande WalleDepartment of Pediatric Nephrology, Ghent University Hospital, Erknet Center, C4C Ghent, Belgium.
Joshua ZaritskyDepartment of Nephrology, Phoenix Children's Hospital, Phoenix, AZ, USA.
Michiel F SchreuderDepartment of Pediatric Nephrology, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
Mieczyslaw LitwinDepartment of Nephrology and Arterial Hypertension, Children's Memorial Health Institute, Warsaw, Poland.
Andrea ScaliseBayer Hispania, S.L, Sant Joan Despi, Barcelona, Spain.
Helen ScottBayer U.S Pharmaceuticals, Whippany, NJ, USA.
James PottsBayer U.S Pharmaceuticals, Whippany, NJ, USA.
Pablo IveliBayer AG, Wuppertal, Germany.
Stefanie BreitensteinBayer AG, Wuppertal, Germany.
Bradley A WaradyDepartment of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41639728
PMCPMC12869910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.